Literature DB >> 3968436

Extracellular release of rat eosinophil peroxidase (EPO) I. Role of anaphylactic immunoglobulins.

J Khalife, M Capron, J M Grzych, H Bazin, A Capron.   

Abstract

The release of intracellular peroxidase (EPO) was investigated in order to evaluate rat eosinophil activation by various immunoglobulin (Ig) isotypes. After successive incubations with purified rat IgG1, IgG2a, IgG2b, IgG2c, IgE, or IgM and their respective anti-Ig antisera, eosinophils released significant amounts of EPO (up to 26% of the intracellular content) only in the case of Ig with anaphylactic activities (IgG2a and IgE). Other classes and subclasses were unable to induce EPO exocytosis. Selective depletion and reconstitution experiments suggested that mast cells were not required in this process. Similar levels of EPO could be released after interaction of eosinophils with antigen-antibody complexes (IgG2a monoclonal antibody and Schistosoma mansoni antigen) immobilized on nonphagocytosable surfaces. These results indicate that EPO exocytosis can be obtained after cell activation with specific antibodies, and that this mechanism is independent of phagocytosis. A kinetic study of eosinophils from S. mansoni-infected rats revealed that IgG2a and IgE cytophilic antibodies induced EPO release after incubation with either specific antisera or specific antigen, which suggests the in vivo relevance of such findings. The present work underlines the parallelism of interaction of anaphylactic-type Ig with eosinophils and with mast cells. Moreover, EPO release seems to represent an interesting marker of eosinophil activation, because close relationships were established between the present findings and previous work on the effector function of rat eosinophils.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968436

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains.

Authors:  A Yokota; K Yukawa; A Yamamoto; K Sugiyama; M Suemura; Y Tashiro; T Kishimoto; H Kikutani
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 2.  The IgE receptor of eosinophils.

Authors:  M Capron; L Prin
Journal:  Springer Semin Immunopathol       Date:  1990

Review 3.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

Review 4.  New properties and roles for eosinophils in disease: discussion paper.

Authors:  C J Spry
Journal:  J R Soc Med       Date:  1985-10       Impact factor: 5.344

5.  Uptake of human eosinophil peroxidase by human neutrophils.

Authors:  G Zabucchi; R Menegazzi; M R Soranzo; P Patriarca
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

6.  Mature eosinophils stimulated to develop in human-cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. II. Vesicular transport of specific granule matrix peroxidase, a mechanism for effecting piecemeal degranulation.

Authors:  A M Dvorak; S J Ackerman; T Furitsu; P Estrella; L Letourneau; T Ishizaka
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

7.  Mutual influence between eosinophil peroxidase (EPO) and neutrophils: neutrophils reversibly inhibit EPO enzymatic activity and EPO increases neutrophil adhesiveness.

Authors:  G Zabucchi; R Menegazzi; R Cramer; E Nardon; P Patriarca
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

8.  Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.

Authors:  C Kroegel; T Yukawa; G Dent; P Chanez; K F Chung; P J Barnes
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

9.  Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation.

Authors:  M Kaneko; M C Swanson; G J Gleich; H Kita
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells.

Authors:  G Plaetinck; J Van der Heyden; J Tavernier; I Faché; T Tuypens; S Fischkoff; W Fiers; R Devos
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.